Home LiteratureArticle Details
PMID: 14654047 Published · ppublish English Comparative Study Journal Article

Advanced glycation end product ligands for the receptor for advanced glycation end products: biochemical characterization and formation kinetics.

Analytical biochemistry ·Vol. 324 ·No. 1 ·2004-01-01 ·Pages 68-78

Valencia JV, Weldon SC, Quinn D, Kiers GH, DeGroot J, TeKoppele JM, Hughes TE

Abstract

Advanced glycation end products (AGEs) accumulate with age and at an accelerated rate in diabetes. AGEs bind cell-surface receptors including the receptor for advanced glycation end products (RAGE). The dependence of RAGE binding on specific biochemical characteristics of AGEs is currently unknown. Using standardized procedures and a variety of AGE measures, the present study aimed to characterize the AGEs that bind to RAGE and their formation kinetics in vitro. To produce AGEs with varying RAGE binding affinity, bovine serum albumin (BSA) AGEs were prepared with 0.5M glucose, fructose, or ribose at times of incubation from 0 to 12 weeks or for up to 3 days with glycolaldehyde or glyoxylic acid. The AGE-BSAs were characterized for RAGE binding affinity, fluorescence, absorbance, carbonyl content, reactive free amine content, molecular weight, pentosidine content, and N-epsilon-carboxymethyl lysine content. Ribose-AGEs bound RAGE with high affinity within 1 week of incubation in contrast to glucose- and fructose-AGE, which required 12 and 6 weeks, respectively, to generate equivalent RAGE ligands (IC50=0.66, 0.93, and 1.7 microM, respectively). Over time, all of the measured AGE characteristics increased. However, only free amine content robustly correlated with RAGE binding affinity. In addition, detailed protocols for the generation of AGEs that reproducibly bind RAGE with high affinity were developed, which will allow for further study of the RAGE-AGE interaction.

MeSH Terms
Acetaldehyde/analogs & derivatives,chemistry,metabolism Amines/analysis Arginine/analogs & derivatives,analysis Diabetes Mellitus/metabolism Fructose/chemistry,metabolism Glucose/chemistry,metabolism Glycation End Products, Advanced/chemical synthesis,metabolism Glyoxylates/chemistry,metabolism Humans Ligands Lysine/analogs & derivatives,analysis,chemistry,metabolism Membrane Proteins/metabolism Molecular Weight Receptor for Advanced Glycation End Products Receptors, Immunologic/biosynthesis,chemistry,metabolism Recombinant Proteins/biosynthesis Regression Analysis Ribose/chemistry,metabolism Serum Albumin, Bovine/chemistry,metabolism Spectrometry, Fluorescence
Chemicals
Amines Glycation End Products, Advanced Glyoxylates Ligands Membrane Proteins Receptor for Advanced Glycation End Products Receptors, Immunologic Recombinant Proteins Serum Albumin, Bovine Fructose Ribose N(6)-carboxymethyllysine Arginine pentosidine Acetaldehyde Glucose glyoxylic acid Lysine glycolaldehyde
Authors & Affiliations
7 authors, click to expand affiliations / ORCID
Valencia Jessica V
Novartis Institutes for BioMedical Research, 100 Technology Square, Bldg. 601/Rm. 5155, Cambridge, MA 02139, USA.
Weldon Stephen C
Quinn Douglas
Kiers Geesje H
DeGroot Jeroen
TeKoppele Johan M
Hughes Thomas E
Article Info
Journal
Analytical biochemistry
Abbr.
Anal Biochem
ISSN
0003-2697
Published
2004-01-01
Pages
68-78
Language
English
Region
United States
NLM ID
0370535
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com